Summary
Anglo-Swedish pharmaceutical company AstraZeneca yesterday reported that first-quarter profit rose by 29%, but cautioned that comparisons will be tougher in the second half of the year when a key patent expires.
For the three months ending March 31, AstraZeneca said net profit was $2.9 billion (pound(s)1.89bn), compared with $2.3bn in the same period a year ago. Revenue rose 11% to $8.6bn, a 7% increase on a constant exchange rates basis.See the full content of this document
Extract
Astrazeneca Profits Up 29% Ahead of Tough Second Half
The strong performa...
See the full content of this document
Sponsored links
